Number of the records: 1
Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose
- 1.
SYSNO ASEP 0347887 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose Author(s) Wohl, P. (CZ)
Krušinová, E. (CZ)
Hill, M. (CZ)
Kratochvílová, S. (CZ)
Zídková, K. (CZ)
Kopecký, J. (CZ)
Neškudla, T. (CZ)
Pravenec, Michal (FGU-C) RID, ORCID
Klementová, M. (CZ)
Vrbíková, J. (CZ)
Wohl, P. (CZ)
Mlejnek, Petr (FGU-C) RID, ORCID
Pelikánová, T. (CZ)Source Title European Journal of Endocrinology - ISSN 0804-4643
Roč. 163, č. 4 (2010), s. 573-583Number of pages 11 s. Language eng - English Country DK - Denmark Keywords telmisartan ; insulin resistance ; adipokines Subject RIV FB - Endocrinology, Diabetology, Metabolism, Nutrition R&D Projects NR9359 GA MZd - Ministry of Health (MZ) NS10528 GA MZd - Ministry of Health (MZ) CEZ AV0Z50110509 - FGU-C (2005-2011) UT WOS 000281859600010 DOI 10.1530/EJE-10-0436 Annotation Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization was analyzed during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose. Despite the decrease in fasting plasma glucose, telmisartan does not improve insulin sensitivity and substrate utilization Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2011
Number of the records: 1